|
Treatments for tuberculosis and non-tuberculous mycobacterial infections: N-aroyl-N-aryl-phenylalaninamides (AAPs)
Invention Summary:
AAPs are novel orally available compounds for treatment for treatment of tuberculosis (TB) and non-tuberculous mycobacterial (NTM) infections--including drug-resistant, multi‑drug‑resistant (MDR), and extensively-drug-resistant (XDR) strains.
Researchers indicate that AAPs potently inhibit mycobacterial RNA polymerase...
Published: 1/31/2025
|
Inventor(s): Richard Ebright, Yon Ebright, Soma Mandal
Keywords(s): Antibacterial
Category(s): Technology Classifications > Healthcare & Life Sciences, Technology Classifications > Therapeutics
|
